Concepedia

Charles Carrieri

CC

Statistics

Publications

2

Citations

56

H-Index

2

Active since

2009

Affiliations

Pfizer (United States)(Current)

Charles Carrieri is an author at Pfizer (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

MedicineNeurologyNeurosciencePharmacologyNeuroprotectionNeuropharmacologyAlzheimer's DiseaseNeurodegenerative DiseasesBiomarkersBiochemistry

Publications per year

2009–2019

2

Publications

2

Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator, <scp>PF</scp>‐06648671, on <scp>CSF</scp> Amyloid‐β Peptides in Randomized Phase I Studies

Jae Eun Ahn, Charles Carrieri, Fernando Dela Cruz et al. · Clinical Pharmacology & Therapeutics · 2019 · 32 citations · Full text

γ‐Secretase Modulator, Neurochemical Biomarkers, Peptide Science +19

P2‐240: PF‐04447943, a novel PDE9A inhibitor, increases cGMP levels in cerebrospinal fluid: Translation from non‐clinical species to healthy human volunteers

Timothy Nicholas, Rebecca Evans, Scot Styren et al. · Alzheimer s & Dementia · 2009 · 24 citations

Synaptic Transmission, Novel Pde9a Inhibitor, Neurochemical Biomarkers +22

1–2 of 2